We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
176
Convergence Investment Partners
Florida
– -$1.01M -18,763 Closed
HI
177
Hendershot Investments
Virginia
– -$952K -17,662 Closed
JMPWA
178
JP Morgan Private Wealth Advisors
California
– -$938K -17,392 Closed
CCMG
179
Clark Capital Management Group
Pennsylvania
– -$936K -17,356 Closed
FWIA
180
Fort Washington Investment Advisors
Ohio
– -$934K -17,325 Closed
MAM
181
Meeder Asset Management
Ohio
– -$919K -17,045 Closed
AAMU
182
Amundi Asset Management US
Massachusetts
– -$903K -16,755 Closed
TRIM
183
Thompson Rubinstein Investment Management
Oregon
– -$892K -16,538 Closed
EP
184
Elkfork Partners
Oregon
– -$889K -16,490 Closed
GCC
185
Game Creek Capital
Massachusetts
– -$860K -15,954 Closed
HS
186
HighVista Strategies
Massachusetts
– -$860K -15,954 Closed
PCM
187
Parsons Capital Management
Rhode Island
– -$856K -15,882 Closed
COPPSERS
188
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$852K -15,798 Closed
TAF
189
Tredje AP-fonden
Sweden
– -$835K -15,492 Closed
CB
190
Commerce Bank
Missouri
– -$813K -15,091 Closed
Baird Financial Group
191
Baird Financial Group
Wisconsin
– -$811K -15,032 Closed
NMIMC
192
Northwestern Mutual Investment Management Company
Wisconsin
– -$764K -14,165 Closed
B
193
BP
United Kingdom
– -$755K -14,000 Closed
CGH
194
Crossmark Global Holdings
Texas
– -$752K -13,939 Closed
CSS
195
Cubist Systematic Strategies
Connecticut
– -$749K -13,885 Closed
Creative Planning
196
Creative Planning
Kansas
– -$746K -13,836 Closed
GHCM
197
Glen Harbor Capital Management
California
– -$732K -13,580 Closed
Commonwealth Equity Services
198
Commonwealth Equity Services
Massachusetts
– -$731K -13,555 Closed
Janney Montgomery Scott
199
Janney Montgomery Scott
Pennsylvania
– -$722K -13,394 Closed
SAM
200
Securian Asset Management
Minnesota
– -$718K -13,322 Closed
6 7
8
9 10

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.